Bruker Net Profit Margin 2012-2026 | BRKR
Current and historical net profit margin for Bruker (BRKR) from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue. Bruker net profit margin for the three months ending March 31, 2026 was .
| Bruker Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2026-03-31 | $3.46B | $-0.04B | -1.01% |
| 2025-12-31 | $3.44B | $-0.02B | -0.64% |
| 2025-09-30 | $3.44B | $-0.02B | -0.67% |
| 2025-06-30 | $3.44B | $0.08B | 2.32% |
| 2025-03-31 | $3.45B | $0.08B | 2.32% |
| 2024-12-31 | $3.37B | $0.11B | 3.39% |
| 2024-09-30 | $3.24B | $0.31B | 9.44% |
| 2024-06-30 | $3.12B | $0.35B | 11.31% |
| 2024-03-31 | $3.00B | $0.40B | 13.40% |
| 2023-12-31 | $2.96B | $0.43B | 14.44% |
| 2023-09-30 | $2.82B | $0.32B | 11.32% |
| 2023-06-30 | $2.71B | $0.32B | 11.75% |
| 2023-03-31 | $2.62B | $0.31B | 11.91% |
| 2022-12-31 | $2.53B | $0.30B | 11.74% |
| 2022-09-30 | $2.51B | $0.28B | 11.02% |
| 2022-06-30 | $2.48B | $0.28B | 11.11% |
| 2022-03-31 | $2.46B | $0.28B | 11.51% |
| 2021-12-31 | $2.42B | $0.28B | 11.50% |
| 2021-09-30 | $2.36B | $0.27B | 11.47% |
| 2021-06-30 | $2.27B | $0.24B | 10.51% |
| 2021-03-31 | $2.12B | $0.20B | 9.63% |
| 2020-12-31 | $1.99B | $0.16B | 7.95% |
| 2020-09-30 | $1.96B | $0.16B | 8.06% |
| 2020-06-30 | $1.97B | $0.17B | 8.38% |
| 2020-03-31 | $2.04B | $0.18B | 8.75% |
| 2019-12-31 | $2.07B | $0.20B | 9.56% |
| 2019-09-30 | $2.03B | $0.21B | 10.22% |
| 2019-06-30 | $1.97B | $0.19B | 9.58% |
| 2019-03-31 | $1.93B | $0.18B | 9.50% |
| 2018-12-31 | $1.90B | $0.18B | 9.44% |
| 2018-09-30 | $1.87B | $0.10B | 5.23% |
| 2018-06-30 | $1.84B | $0.09B | 4.99% |
| 2018-03-31 | $1.81B | $0.08B | 4.63% |
| 2017-12-31 | $1.77B | $0.08B | 4.47% |
| 2017-09-30 | $1.71B | $0.15B | 8.85% |
| 2017-06-30 | $1.66B | $0.16B | 9.68% |
| 2017-03-31 | $1.62B | $0.15B | 9.44% |
| 2016-12-31 | $1.61B | $0.16B | 9.62% |
| 2016-09-30 | $1.62B | $0.15B | 9.08% |
| 2016-06-30 | $1.62B | $0.11B | 6.91% |
| 2016-03-31 | $1.65B | $0.12B | 7.23% |
| 2015-12-31 | $1.62B | $0.10B | 6.28% |
| 2015-09-30 | $1.65B | $0.07B | 4.05% |
| 2015-06-30 | $1.68B | $0.06B | 3.64% |
| 2015-03-31 | $1.74B | $0.06B | 3.16% |
| 2014-12-31 | $1.81B | $0.06B | 3.15% |
| 2014-09-30 | $1.85B | $0.07B | 3.56% |
| 2014-06-30 | $1.87B | $0.08B | 4.11% |
| 2014-03-31 | $1.87B | $0.08B | 4.49% |
| 2013-12-31 | $1.84B | $0.08B | 4.35% |
| 2013-09-30 | $1.80B | $0.06B | 3.22% |
| 2013-06-30 | $1.81B | $0.08B | 4.47% |
| 2013-03-31 | $1.78B | $0.07B | 3.82% |
| 2012-12-31 | $1.79B | $0.08B | 4.35% |
| 2012-09-30 | $1.75B | $0.10B | 5.94% |
| 2012-06-30 | $1.72B | $0.08B | 4.88% |
| 2012-03-31 | $1.70B | $0.10B | 5.65% |
| 2011-12-31 | $1.65B | $0.09B | 5.57% |
| 2011-09-30 | $1.59B | $0.08B | 5.15% |
| 2011-06-30 | $1.48B | $0.09B | 6.00% |
| 2011-03-31 | $1.38B | $0.09B | 6.50% |
| 2010-12-31 | $1.31B | $0.10B | 7.28% |
| 2010-09-30 | $1.26B | $0.11B | 8.76% |
| 2010-06-30 | $1.21B | $0.10B | 8.18% |
| 2010-03-31 | $1.16B | $0.09B | 7.66% |
| 2009-12-31 | $1.12B | $0.08B | 7.26% |
| 2009-09-30 | $1.06B | $0.06B | 5.92% |
| 2009-06-30 | $1.04B | $0.07B | 6.24% |
| 2009-03-31 | $1.10B | $0.07B | 6.73% |
| 2008-12-31 | $1.11B | $0.07B | 5.87% |
| 2008-09-30 | $1.14B | $0.08B | 6.95% |
| 2008-06-30 | $1.14B | $0.09B | 7.74% |
| 2008-03-31 | $1.06B | $0.08B | 7.90% |
| 2007-12-31 | $1.03B | $0.10B | 9.58% |
| 2007-09-30 | $1.24B | $0.13B | 10.09% |
| 2007-06-30 | $1.10B | $0.10B | 9.17% |
| 2007-03-31 | $0.96B | $0.09B | 8.92% |
| 2006-12-31 | $0.85B | $0.08B | 8.81% |
| 2006-09-30 | $0.44B | $0.02B | 3.64% |
| 2006-06-30 | $0.42B | $0.02B | 3.56% |
| 2006-03-31 | $0.39B | $0.01B | 3.06% |
| 2005-12-31 | $0.37B | $0.01B | 2.42% |
| 2005-09-30 | $0.39B | $0.01B | 1.28% |
| 2005-06-30 | $0.37B | 0 | 0.00% |
| 2005-03-31 | $0.36B | $0.00B | -1.10% |
| 2004-12-31 | $0.36B | $0.00B | -1.12% |
| 2004-09-30 | $0.27B | $-0.01B | -2.57% |
| 2004-06-30 | $0.27B | $-0.02B | -7.06% |
| 2004-03-31 | $0.27B | $-0.02B | -6.39% |
| 2003-12-31 | $0.26B | $-0.02B | -7.28% |
| 2003-09-30 | $0.30B | $-0.02B | -8.08% |
| 2003-06-30 | $0.29B | $-0.01B | -2.75% |
| 2003-03-31 | $0.26B | $-0.01B | -3.88% |
| 2002-12-31 | $0.22B | $-0.01B | -3.17% |
| 2002-09-30 | $0.22B | $-0.01B | -3.67% |
| 2002-06-30 | $0.19B | $-0.01B | -4.32% |
| 2002-03-31 | $0.18B | $0.00B | -1.68% |
| 2001-12-31 | $0.18B | $0.00B | -1.71% |
| 2001-09-30 | $0.09B | $0.00B | 4.44% |
| 2001-06-30 | $0.09B | $0.00B | 4.49% |
| 2001-03-31 | $0.09B | $0.00B | 3.53% |
| 2000-12-31 | $0.08B | $0.00B | 2.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |